Cutaneous follicle center lymphoma, intra-abd lymph nodes is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in the skin and intra-abdominal lymph nodes. This condition is clinically significant as it can lead to systemic symptoms and requires accurate diagnosis for effective treatment. The ICD-10 Code C82.63 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can track and manage this condition appropriately.
ICD-10 Code C82.63 represents Cutaneous follicle center lymphoma affecting intra-abdominal lymph nodes. This condition involves malignant transformation of follicle center B-cells, leading to lymphadenopathy and potential systemic involvement. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Cutaneous follicle center lymphoma, intra-abd lymph nodes is a rare form of non-Hodgkin lymphoma that primarily affects the skin and can involve intra-abdominal lymph nodes. The exact cause remains unclear, but it is associated with genetic mutations and environmental factors. Early diagnosis and treatment are crucial to prevent progression and complications.
ICD-10 Code C82.63 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.
In SOAP notes, ICD-10 Code C82.63 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous follicle center lymphoma affecting intra-abdominal lymph nodes. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Cutaneous follicle center lymphoma, intra-abd lymph nodes requires prompt medical intervention to prevent disease progression. Treatment may include chemotherapy, radiation therapy, or targeted therapies based on the patient's specific condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.63 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description | 
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. | 
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. | 
| 77014 | Radiologic examination, lymphatic system, including lymphangiography. | 
| 99214 | Established patient office visit, moderate complexity. | 
Common Questions About Using ICD-10 Code C82.63 for Cutaneous follicle center lymphoma, intra-abd lymph nodes
What are the common symptoms of Cutaneous follicle center lymphoma?
Common symptoms include painless swelling of lymph nodes, skin lesions, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Cutaneous follicle center lymphoma diagnosed?
Diagnosis typically involves a physical examination, imaging studies, and biopsy of affected lymph nodes or skin lesions to confirm the presence of follicle center B-cells.
What treatments are available for this condition?
Treatment options may include chemotherapy, radiation therapy, and targeted therapies. Supportive care is also important to manage symptoms and improve quality of life.
Is Cutaneous follicle center lymphoma contagious?
No, Cutaneous follicle center lymphoma is not contagious. It is a malignancy of the lymphatic system and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes